IMNM
Price
$12.01
Change
-$0.43 (-3.46%)
Updated
Dec 17, 04:59 PM (EDT)
98 days until earnings call
INZY
Price
$2.92
Change
-$0.10 (-3.31%)
Updated
Dec 17, 04:59 PM (EDT)
92 days until earnings call
Ad is loading...

IMNM vs INZY

Header iconIMNM vs INZY Comparison
Open Charts IMNM vs INZYBanner chart's image
Immunome
Price$12.01
Change-$0.43 (-3.46%)
Volume$8.47K
CapitalizationN/A
Inozyme Pharma
Price$2.92
Change-$0.10 (-3.31%)
Volume$5.25K
CapitalizationN/A
IMNM vs INZY Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. INZY commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and INZY is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (IMNM: $12.02 vs. INZY: $2.94)
Brand notoriety: IMNM and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 117% vs. INZY: 94%
Market capitalization -- IMNM: $750.25M vs. INZY: $188.87M
IMNM [@Biotechnology] is valued at $750.25M. INZY’s [@Biotechnology] market capitalization is $188.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, IMNM is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 5 bearish.
  • INZY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -13.53% price change this week, while INZY (@Biotechnology) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.83%. For the same industry, the average monthly price growth was +1.09%, and the average quarterly price growth was +9.71%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 26, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-4.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($750M) has a higher market cap than INZY($189M). IMNM YTD gains are higher at: 12.336 vs. INZY (-30.986). INZY has higher annual earnings (EBITDA): -90.3M vs. IMNM (-109.95M). IMNM has more cash in the bank: 240M vs. INZY (132M). IMNM has less debt than INZY: IMNM (2.72M) vs INZY (46.8M). IMNM has higher revenues than INZY: IMNM (10.1M) vs INZY (0).
IMNMINZYIMNM / INZY
Capitalization750M189M397%
EBITDA-109.95M-90.3M122%
Gain YTD12.336-30.986-40%
P/E RatioN/AN/A-
Revenue10.1M0-
Total Cash240M132M182%
Total Debt2.72M46.8M6%
TECHNICAL ANALYSIS
Technical Analysis
IMNMINZY
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJEAX15.99N/A
N/A
PGIM US Real Estate A
MOGLX9.50N/A
N/A
Gabelli Media Mogul
JLVRX20.66-0.13
-0.63%
JPMorgan Large Cap Value R5
IJSIX17.20-0.21
-1.21%
VY® JPMorgan Small Cap Core Equity I
JSVQX28.82-0.41
-1.40%
JPMorgan Small Cap Value R4

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-3.38%
BEAM - IMNM
45%
Loosely correlated
-1.21%
INZY - IMNM
45%
Loosely correlated
-2.65%
TNYA - IMNM
44%
Loosely correlated
-51.04%
ATXS - IMNM
44%
Loosely correlated
-1.24%
XNCR - IMNM
42%
Loosely correlated
+2.12%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-2.65%
BEAM - INZY
57%
Loosely correlated
-1.21%
NAUT - INZY
53%
Loosely correlated
-1.00%
ABOS - INZY
49%
Loosely correlated
-0.51%
DNLI - INZY
49%
Loosely correlated
-0.30%
RXRX - INZY
48%
Loosely correlated
-4.30%
More